Skip to main content
Earnings Labs
Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc. (FATE) Earnings

NASDAQ·Healthcare·Biotechnology

$2.08

+1.22%

Mkt Cap $241.28M

EPS — Estimate vs Actual

Mkt Cap

$241.28M

P/E

—

Fwd P/E

—

P/S

38.20

Rev TTM

—

EPS TTM

-$1.09